| Product Code: ETC12838656 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Malta continues to rely on key exporting countries such as India, Israel, Ireland, Germany, and Belgium for its influenza medication imports in 2024. The high concentration of the Herfindahl-Hirschman Index (HHI) indicates a competitive market among these top exporting nations. With a notable Compound Annual Growth Rate (CAGR) of 10.1% from 2020 to 2024 and a significant growth rate of 29.61% in 2023-24, the demand for influenza medications in Malta is evidently on the rise, showcasing opportunities for market expansion and strategic partnerships in the pharmaceutical industry.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Influenza Medications Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Influenza Medications Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Influenza Medications Market - Industry Life Cycle |
3.4 Malta Influenza Medications Market - Porter's Five Forces |
3.5 Malta Influenza Medications Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Malta Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Malta Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
4 Malta Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination |
4.2.2 Growing elderly population in Malta |
4.2.3 Rising prevalence of influenza cases in the region |
4.3 Market Restraints |
4.3.1 Stringent regulations governing the pharmaceutical industry in Malta |
4.3.2 Limited healthcare infrastructure and resources |
4.3.3 Competition from alternative treatments like home remedies and natural supplements |
5 Malta Influenza Medications Market Trends |
6 Malta Influenza Medications Market, By Types |
6.1 Malta Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Malta Influenza Medications Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Malta Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2021 - 2031F |
6.1.4 Malta Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2021 - 2031F |
6.2 Malta Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Malta Influenza Medications Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Malta Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2021 - 2031F |
6.2.4 Malta Influenza Medications Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 Malta Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Malta Influenza Medications Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Malta Influenza Medications Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Malta Influenza Medications Market Revenues & Volume, By Geriatric, 2021 - 2031F |
7 Malta Influenza Medications Market Import-Export Trade Statistics |
7.1 Malta Influenza Medications Market Export to Major Countries |
7.2 Malta Influenza Medications Market Imports from Major Countries |
8 Malta Influenza Medications Market Key Performance Indicators |
8.1 Percentage increase in influenza vaccination rates in Malta |
8.2 Number of influenza cases reported annually in Malta |
8.3 Adoption rate of new influenza medications in the market |
9 Malta Influenza Medications Market - Opportunity Assessment |
9.1 Malta Influenza Medications Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Malta Influenza Medications Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Malta Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
10 Malta Influenza Medications Market - Competitive Landscape |
10.1 Malta Influenza Medications Market Revenue Share, By Companies, 2024 |
10.2 Malta Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here